Key Expert – Cancer Treatment Protocols Expert (Cat. II)

Project: Technical Assistance to the Syrian Ministry of Health – Strengthening Institutional Capacity and Governance.

Location: Damascus, Syria

Indicative Start Date: 9 December 2026

Implementation Period: 14 months (indicative end date: 9 February 2028)

NTU International is currently identifying qualified experts for the

EU-funded

The assignment aims to support the institutional strengthening and governance capacities of the Syrian Ministry of Health, contributing to more effective institutional performance, evidence-based decision-making, accountability and sustainable capacity development.

In this context, we are seeking a highly qualified

Key Expert – Cancer Treatment Protocols Expert (Cat. II)

Qualifications and Skills Required

• Medical degree with board certification or equivalent specialisation

  in

  Clinical Oncology, Medical Oncology, Haematology-Oncology

  or

  Clinical Pharmacology

  .
• A

  Master's degree in Public Health or a related field

  is considered an

  asset

  .
• Strong capacity to harmonise cancer treatment practices across geographically dispersed and unevenly resourced oncology centres.
• Sound understanding of

  pharmaceutical supply-chain and quality-assurance considerations

  affecting essential cancer medicines.
• Ability to facilitate

  consensus-building among clinical stakeholders

  on standardised, evidence-based treatment pathways.
• Prior experience supporting ministries of health or national cancer-control programmes in post-conflict or early-recovery contexts is strongly preferred.

General Professional Experience

• Minimum

  10 years of clinical or technical experience in medical oncology,

  including substantial direct experience in the development, harmonisation or revision of national or institutional systemic anti-cancer therapy protocols, particularly

  chemotherapy protocols

  .

Specific Professional Experience

• Demonstrated familiarity with

  current international treatment guidelines

  (e.g.

  WHO Essential Medicines List for cancer

  ,

  NCCN

  ,

  ESMO

  ) and their contextual adaptation to resource-constrained or fragile health systems.
• Proven experience developing or strengthening pharmacovigilance and medication-safety systems specific to chemotherapy administration, including

  adverse-event reporting, dose-verification protocols

  and

  safe-handling procedures

  .
• Experience designing

  structured clinical training programmes for oncology teams

  (physicians, pharmacists and nursing staff) on protocol implementation,

  treatment sequencing

  and

  toxicity management

  .
• Experience developing

  monitoring and evaluation tools

  to track

  treatment adherence

  ,clinical outcomes and protocol-related safety indicators across

  multiple oncology centres

  .

Language Requirements

• English: Excellent written and spoken command –

  mandatory

  .
• Arabic: Working knowledge is considered a

  strong asset

  .

If you are interested in this opportunity, please apply and upload your CV via LinkedIn or send to recruitment@ntu.eu. Please note that only selected candidates will be contacted due to the large amount of applicants.